查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1485767

奈米药物市场，按形态、按应用、按适应症、按分子类型、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Nanomedicines Market, By Modality, By Application, By Indication, By Molecule Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年奈米药物市场规模为2.3104亿美元，2024年至2032年复合年增长率为12.92%。

奈米药物市场-市场动态

奈米技术在药物传输方法的应用迅速增加，以推动市场需求

基于奈米技术的药物传输方法的采用正在快速增长，这得益于其在靶向输送、增强药物疗效和减少副作用方面所提供的优势。这种成长的推动因素包括研发投资的增加、奈米材料和药物传输技术的进步以及对个人化和精准医疗解决方案不断增长的需求。此外，随着基于奈米医学的疫苗和治疗方法的开发来对抗病毒，COVID-19大流行进一步加速了奈米技术在药物传输中的采用。

奈米药物市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 12.92% 左右的复合年增长率成长

根据模式细分，治疗预计将在 2023 年显示最大的市场份额

从应用细分来看，2023年药物传递是主导类型

基于适应症细分，心血管

是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

奈米药物市场-細項分析：

全球奈米药物市场根据形态、应用、适应症、分子类型和区域进行细分。

根据形式，市场分为两类： 治疗涉及使用奈米药物进行治疗，针对特定疾病或医疗状况。诊断通常透过先进的成像或检测方法利用奈米技术来诊断疾病或病症。

根据应用，市场分为两类：药物输送专注于使用奈米药物进行标靶药物输送，增强药物疗效并最大限度地减少副作用。 IVD 利用奈米技术在体外进行诊断测试，例如血液测试或基因测试。植入物涉及在医疗植入物（例如骨科植入物或牙科植入物）中使用奈米材料，以提高生物相容性和性能。

奈米药物市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

北美和欧洲是关键参与者，拥有先进的研究基础设施、健全的监管框架以及对奈米医学研究和开发的大量投资。同时，在医疗保健支出增加、慢性病盛行率增加以及创新疗法普及的推动下，亚太地区展现出巨大的成长潜力。拉丁美洲以及中东和非洲地区也提供了市场扩张的机会，儘管面临医疗基础设施、负担能力和监管复杂性的挑战。

奈米药物市场-竞争格局：

一些关键参与者正在透过研发投资、併购和策略合作伙伴关係等策略主导市场。雅培（Abbott Laboratories）、强生（Johnson & Johnson）和辉瑞（Pfizer）等公司凭藉多样化的奈米医学产品组合和广泛的全球影响力引领市场。此外，安进（Amgen）、吉利德科学（Gilead Sciences）和诺华（Novartis）等创新生物技术公司透过突破性疗法和新型候选药物为市场竞争力做出了贡献。随着竞争的加剧，企业专注于透过产品创新、监管审批和市场扩张努力来实现差异化。

最近的发展：

2022 年 1 月，辉瑞公司和 Acuitas Therapeutics 披露了一项开发和选择协议，其中辉瑞将有机会获得 Acuitas 的 LNP 技术许可，以非独家的方式用于疫苗或治疗开发的多达 10 个目标。

目录

第一章：奈米药物市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按形态分類的奈米药物市场片段
    • 奈米药物市场片段（按应用）
    • 按适应症分類的奈米药物市场片段
    • 按分子类型分類的奈米药物市场片段
    • 按国家/地区分類的奈米药物市场摘要
    • 按地区分類的奈米药物市场片段
  • 竞争洞察

第 3 章：奈米药物主要市场趋势

  • 奈米药物市场驱动因素
    • 市场驱动因素的影响分析
  • 奈米药物市场限制
    • 市场限制影响分析
  • 奈米药物市场机会
  • 奈米药物市场未来趋势

第 4 章：奈米药物产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：奈米药物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：奈米药物市场格局

  • 2023 年奈米药物市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：奈米药物市场 - 按形态

  • 概述
    • 按方式分類的细分市场占有率分析
    • 治疗
    • 诊断

第 8 章：奈米药物市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 药物输送
    • 体外诊断
    • 注入
    • 疫苗
    • 其他的

第 9 章：奈米药物市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 肿瘤学
    • 传染性
    • 心血管
    • 神经病学

第 10 章：奈米药物市场 - 按分子类型

  • 概述
    • 按应用分類的细分市场占有率分析
    • 奈米粒子
    • 奈米管
    • 奈米装置

第 11 章：奈米药物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美奈米药物主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按方式）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按分子类型）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲奈米药物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按方式）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按分子类型）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区奈米药物主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按方式）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模与预测（依分子类型）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲奈米药物主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按方式）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模与预测（按分子类型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲奈米药物主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按方式）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按分子类型）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 奈米药物产业

  • 竞争仪表板
  • 公司简介
    • Sanofi SA
    • Celgene Corporation
    • Nanobiotix
    • Luminex Corporation
    • Nanospectra Biosciences Inc
    • NanoCarrier Co. Ltd
    • Johnson & Johnson Services Inc
    • Merck & Co., Inc
    • Pfizer, Inc.
    • NanoCarrier Co. Ltd
    • Taiwan Liposome Company Ltd
    • Hoffmann-La Roche AG (Roche)
    • Gilead Science Inc
    • Ipsen SA.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2665

REPORT HIGHLIGHT

Nanomedicines Market size was valued at USD 231.04 Million in 2023, expanding at a CAGR of 12.92% from 2024 to 2032.

The nanomedicine market encompasses the use of nanotechnology for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications. The development of personalized nanomedicines tailored to individual patient profiles, and increasing research focus on combination therapies and multifunctional nanoplatforms. However, restraints in the nanomedicine market include challenges related to regulatory approvals and safety concerns associated with nanomaterials. Opportunities abound in the integration of nanotechnology with other emerging technologies like artificial intelligence and gene editing for precision medicine approaches.

Nanomedicines Market- Market Dynamics

Rapidly increasing utilization of nanotechnology in drug delivery methods to propel market demand

The adoption of nanotechnology-based methods for drug delivery is experiencing rapid growth, driven by the advantages offered in terms of targeted delivery, enhanced drug efficacy, and reduced side effects. This growth is fueled by increasing investments in research and development, advancements in nanomaterials and drug delivery technologies, and a rising demand for personalized and precision medicine solutions. Additionally, the COVID-19 pandemic has further accelerated the adoption of nanotechnology in drug delivery, with the development of nanomedicine-based vaccines and therapeutics to combat the virus.

Nanomedicines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.92% over the forecast period (2024-2032)

Based on Modality segmentation, Treatment was predicted to show maximum market share in the year 2023

Based on application segmentation, Drug Delivery was the leading type in 2023

Based on Indication segmentation, Cardiovascular

was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanomedicines Market- Segmentation Analysis:

The Global Nanomedicines Market is segmented on the basis of Modality, Application, Indication, Molecule Type, and Region.

The market is divided into two categories based on Modality: Treatment involves the use of nanomedicines for therapeutic purposes, targeting specific diseases or medical conditions. Diagnostics utilizes nanotechnology for diagnosing diseases or conditions, often through advanced imaging or detection methods.

The market is divided into two categories based on application: Drug Delivery focuses on the use of nanomedicines for targeted drug delivery, enhancing drug efficacy, and minimizing side effects. IVD utilizes nanotechnology for diagnostic tests performed outside the body, such as blood tests or genetic testing. An implant involves the use of nanomaterials in medical implants, such as orthopedic implants or dental implants, to improve biocompatibility and performance.

Nanomedicines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced research infrastructure, robust regulatory frameworks, and significant investments in nanomedicine research and development. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Nanomedicines Market- Competitive Landscape:

Several key players are dominaning the market through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies like Abbott Laboratories, Johnson & Johnson, and Pfizer lead the market with diverse portfolios of nanomedicine products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Gilead Sciences, and Novartis contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In January 2022, Pfizer Inc. and Acuitas Therapeutics disclosed a development and option agreement, wherein Pfizer will hold the opportunity to license Acuitas' LNP technology for potential utilization in up to ten targets for vaccine or therapeutic development on a non-exclusive basis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMEDICINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Sanofi SA

Celgene Corporation

Nanobiotix

Luminex Corporation

Nanospectra Biosciences Inc

NanoCarrier Co. Ltd

Johnson & Johnson Services Inc

Merck & Co., Inc

Pfizer, Inc.

NanoCarrier Co. Ltd

Taiwan Liposome Company Ltd

Hoffmann-La Roche AG (Roche)

Gilead Science Inc

Ipsen SA.

Others

GLOBAL NANOMEDICINES MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Treatment
  • Diagnostics

GLOBAL NANOMEDICINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • IVD
  • Implant
  • Vaccine
  • Others

GLOBAL NANOMEDICINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Infectious
  • Cardiovascular
  • Neurological

GLOBAL NANOMEDICINES MARKET, BY MOLECULE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanoparticle
  • Nanotube
  • Nanodevice

GLOBAL NANOMEDICINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Nanomedicines Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Nanomedicines Market Snippet by Modality
    • 2.1.2.Nanomedicines Market Snippet by Application
    • 2.1.3.Nanomedicines Market Snippet by Indication
    • 2.1.4.Nanomedicines Market Snippet by Molecule Type
    • 2.1.5.Nanomedicines Market Snippet by Country
    • 2.1.6.Nanomedicines Market Snippet by Region
  • 2.2.Competitive Insights

3.Nanomedicines Key Market Trends

  • 3.1.Nanomedicines Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Nanomedicines Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Nanomedicines Market Opportunities
  • 3.4.Nanomedicines Market Future Trends

4.Nanomedicines Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Nanomedicines Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Nanomedicines Market Landscape

  • 6.1.Nanomedicines Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Nanomedicines Market - By Modality

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Modality, 2023 & 2032 (%)
    • 7.1.2.Treatment
    • 7.1.3.Diagnostics

8.Nanomedicines Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Drug Delivery
    • 8.1.3.IVD
    • 8.1.4.Implant
    • 8.1.5.Vaccine
    • 8.1.6.Others

9.Nanomedicines Market - By Indication

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Infectious
    • 9.1.4.Cardiovascular
    • 9.1.5.Neurological

10.Nanomedicines Market - By Molecule Type

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Nanoparticle
    • 10.1.3.Nanotube
    • 10.1.4.Nanodevice

11.Nanomedicines Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Nanomedicines Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Nanomedicines Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Nanomedicines Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Nanomedicines Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Nanomedicines Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Nanomedicines Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Sanofi SA
    • 12.2.2.Celgene Corporation
    • 12.2.3.Nanobiotix
    • 12.2.4.Luminex Corporation
    • 12.2.5.Nanospectra Biosciences Inc
    • 12.2.6.NanoCarrier Co. Ltd
    • 12.2.7.Johnson & Johnson Services Inc
    • 12.2.8.Merck & Co., Inc
    • 12.2.9.Pfizer, Inc.
    • 12.2.10.NanoCarrier Co. Ltd
    • 12.2.11.Taiwan Liposome Company Ltd
    • 12.2.12.Hoffmann-La Roche AG (Roche)
    • 12.2.13.Gilead Science Inc
    • 12.2.14.Ipsen SA.
    • 12.2.15.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanomedicines Market: Modality Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Modality
  • TABLE Global Nanomedicines Market, by Modality 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanomedicines Market, by Application 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Nanomedicines Market, by Indication 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Molecule Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Molecule Type
  • TABLE Global Nanomedicines Market, by Molecule Type 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanomedicines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)